| Analysis | Metabolite Name | Measured Value | Units | Organ | Cancer status | Smoker | Gender |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 14 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 16 | Peak area | Serum | Adenocarcnoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 21 | Peak area | Plasma | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 23 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 24 | Peak area | Serum | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 27 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 27 | Peak area | Serum | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 29 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 31 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 31 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 32 | Peak area | Plasma | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 32 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 32 | Peak area | Serum | Adenocarcnoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 33 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 33 | Peak area | Serum | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 35 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 35 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 35 | Peak area | Serum | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 36 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 36 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 37 | Peak area | Plasma | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 37 | Peak area | Plasma | Healthy | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 37 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 39 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 39 | Peak area | Serum | Adenocarcnoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 40 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 40 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 41 | Peak area | Plasma | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 41 | Peak area | Serum | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 42 | Peak area | Plasma | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 42 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 42 | Peak area | Serum | Healthy | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 43 | Peak area | Plasma | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 43 | Peak area | Plasma | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 43 | Peak area | Plasma | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 43 | Peak area | Serum | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 43 | Peak area | Serum | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 44 | Peak area | Plasma | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 44 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 44 | Peak area | Serum | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 45 | Peak area | Plasma | Adenocarcnoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 45 | Peak area | Serum | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 45 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 47 | Peak area | Plasma | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 47 | Peak area | Serum | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 48 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 48 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 48 | Peak area | Serum | Adenosquamous | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 49 | Peak area | Plasma | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 49 | Peak area | Plasma | Adenocarcinoma | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 49 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 49 | Peak area | Plasma | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 49 | Peak area | Serum | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 49 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 50 | Peak area | Serum | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 51 | Peak area | Plasma | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 51 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 51 | Peak area | Plasma | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 51 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 52 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 52 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 52 | Peak area | Serum | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 53 | Peak area | Plasma | Adenocarcnoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 53 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 54 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 54 | Peak area | Plasma | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 54 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 55 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 55 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 56 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 56 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 56 | Peak area | Serum | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 57 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 57 | Peak area | Serum | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 57 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 57 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 58 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 58 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 58 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 59 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 59 | Peak area | Plasma | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 59 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 60 | Peak area | Plasma | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 61 | Peak area | Serum | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 61 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 62 | Peak area | Plasma | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 62 | Peak area | Plasma | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 62 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 63 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 63 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 64 | Peak area | Plasma | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 64 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 65 | Peak area | Plasma | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 65 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 66 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 66 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 66 | Peak area | Serum | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 67 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 68 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 68 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 68 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 69 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 69 | Peak area | Serum | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 69 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 70 | Peak area | Plasma | Adenocarcinoma | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 70 | Peak area | Plasma | Healthy | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 70 | Peak area | Plasma | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 71 | Peak area | Plasma | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 71 | Peak area | Serum | Adenocarcinoma | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 71 | Peak area | Serum | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 72 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 73 | Peak area | Plasma | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 74 | Peak area | Plasma | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 74 | Peak area | Serum | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 74 | Peak area | Serum | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 75 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 76 | Peak area | Serum | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 77 | Peak area | Plasma | Adenocarcnoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 80 | Peak area | Plasma | Healthy | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 80 | Peak area | Serum | Healthy | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 81 | Peak area | Plasma | Adenocarcinoma | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 81 | Peak area | Plasma | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 83 | Peak area | Plasma | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 83 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 83 | Peak area | Serum | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 84 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 84 | Peak area | Serum | Adenocarcinoma | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 84 | Peak area | Serum | Adenosquamous | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 84 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 85 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 85 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 86 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 87 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 88 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 90 | Peak area | Plasma | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 90 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 92 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 93 | Peak area | Serum | Healthy | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 94 | Peak area | Serum | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 95 | Peak area | Plasma | Adenosquamous | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 95 | Peak area | Plasma | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 97 | Peak area | Serum | Adenocarcinoma | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 97 | Peak area | Serum | Adenosquamous | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 98 | Peak area | Plasma | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 100 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 101 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 103 | Peak area | Plasma | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 103 | Peak area | Plasma | NA | NA | NA |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 104 | Peak area | Serum | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 105 | Peak area | Plasma | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 106 | Peak area | Plasma | Adenosquamous | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 107 | Peak area | Plasma | Healthy | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 107 | Peak area | Serum | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 107 | Peak area | Serum | Healthy | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 109 | Peak area | Serum | Adenocarcinoma | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 111 | Peak area | Plasma | Adenosquamous | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 111 | Peak area | Serum | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 121 | Peak area | Plasma | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 123 | Peak area | Serum | Adenocarcinoma | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 123 | Peak area | Serum | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 124 | Peak area | Serum | Healthy | Former | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 126 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 126 | Peak area | Serum | Healthy | Current | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 134 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 159 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 167 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 197 | Peak area | Serum | Adenocarcinoma | Current | M |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 202 | Peak area | Plasma | Healthy | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 207 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 662 | Peak area | Plasma | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 749 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 1003 | Peak area | Serum | Adenocarcinoma | Former | F |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 1272 | Peak area | Plasma | Adenocarcinoma | Former | F |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|